Editorial: Kinase inhibitors in cancer therapy

Front Cell Dev Biol. 2022 Oct 31:10:1020297. doi: 10.3389/fcell.2022.1020297. eCollection 2022.
No abstract available

Keywords: Bax/Bcl-2; EGFR pathway; RAS-RAF-MEK-ERK pathway; RET = rearranged during transfection; kinase inhibitors.

Publication types

  • Editorial